Home | Published Research | Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

March 31, 2021

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

Written By

Ruel TD, Capparelli EV, Tierney C, Nelson BS, Coletti A, Bryson Y, et al.